Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 04'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
10:50am, Monday, 03'rd Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy?
01:01pm, Friday, 31'st Jan 2025
Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
04:14pm, Thursday, 30'th Jan 2025
SECAUCUS, N.J. , Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World'
Why Quest Diagnostics Stock Was Blasting Higher Today
04:07pm, Thursday, 30'th Jan 2025
Quest Diagnostics (DGX 5.49%) stock was teasing its all-time high on Thursday, no mean feat for a company that's been publicly traded for decades. The healthcare testing specialist's share price was u
Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript
02:35pm, Thursday, 30'th Jan 2025
Quest Diagnostics Incorporated (NYSE:DGX ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Jim Davis - President & CEO Sam Samad - EVP & CFO Shawn Bevec - VP, IR Conf
Quest Diagnostics EPS Tops Predictions
11:38am, Thursday, 30'th Jan 2025
Quest Diagnostics (DGX 6.36%), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings pe
DGX Stock Dips Despite Q4 Earnings and Revenue Beat, Margins Rise
10:35am, Thursday, 30'th Jan 2025
Quest Diagnostics' fourth-quarter 2024 performance benefits from the strength of its core business.
Quest Diagnostics (DGX) Q4 Earnings and Revenues Top Estimates
08:55am, Thursday, 30'th Jan 2025
Quest Diagnostics (DGX) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.15 per share a year ago.
Fourth quarter revenues of $2.62 billion, up 14.5% from 2023 Fourth quarter reported diluted earnings per share ("EPS") of $1.95, up 14.7% from 2023; and adjusted diluted EPS of $2.23, up 3.7% from 20
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
08:56am, Monday, 27'th Jan 2025
Physicians and patients to benefit from access to Quest's industry-leading test menu and broad health plan relationships in Ohio SECAUCUS, N.J. and CLEVELAND , Jan. 27, 2025 /PRNewswire/ -- Quest Dia
Should Value Investors Buy Quest Diagnostics (DGX) Stock?
10:41am, Friday, 24'th Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Quest Diagnostics Q4 Earnings Preview: What's in Store for the Stock?
08:50am, Thursday, 23'rd Jan 2025
Quest Diagnostics is likely to have driven strong performances in the key physician and hospital channels in the fourth quarter of 2024.
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare
03:46am, Friday, 17'th Jan 2025
Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.
4 Stocks to Monitor in a Dynamic Outpatient Home Health Industry
11:10am, Thursday, 16'th Jan 2025
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poise
